PlantForm

PlantForm Corporation is a biopharmaceutical company specializing in the development and production of antibody and protein drugs using its proprietary vivoXPRESS platform. This plant-based system enables faster, more cost-effective production of biologic drugs for novel indications and new markets. The company's technology utilizes genetically engineered tobacco plants as drug-producing factories, leveraging the plants' well-understood genetics and non-food crop status. This approach can reduce biopharmaceutical production costs by up to 90% compared to traditional mammalian cell systems, while offering high expression rates and minimizing unwanted immune system reactions. PlantForm's pipeline includes biosimilar versions of drugs such as Keytruda and Lucentis, as well as medical countermeasures against terrorism threats like ricin and sarin. The company also develops animal health programs targeting Porcine Epidemic Diarrhea Virus (PEDv) and E.coli infections. PlantForm's manufacturing process can progress from tobacco seed to finished product in as little as six weeks, allowing for efficient production of drugs that may be challenging to manufacture using other systems.